EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease

Michael Weyrich, Sebastian Cremer, Martin Gerster, Tamim Sarakpi, Tina Rasper, Stephen Zewinger iD, Sammy R Patyna iD, David M Leistner iD, Gunnar H Heine, Christoph Wanner iD, Winfried März iD, Danilo Fliser und 3 weitere

Circulation · 03.09.2024 · 150 (10) · 746-757

DOI: 10.1161/circulationaha.124.069139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 03.09.2024. Verfasst von Michael Weyrich und 14 weiteren Autor:innen. Beteiligte Einrichtung: 1Goethe University Frankfurt's University Hospital, Department of Internal Medicine 4, Nephrology (T.S., S.R.P., M.G., T.S., M.W.). Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Chromosomes, Human, Y. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic kidney disease represents one of the strongest risk factors for cardiovascular diseases, and particularly for heart failure. Despite improved pharmaceutical treatments, mortality remains high. Recently, experimental studies demonstrated that mosaic loss of Y chromosome (LOY) associates with cardiac fibrosis in male mice. Since diffuse cardiac fibrosis is the common denominator for progression of all forms of heart failure, we determined the association of LOY on mortality and cardiovascular disease outcomes in patients with chronic kidney disease. METHODS: LOY was quantified in men with stable chronic kidney disease (CARE for HOMe study, n=279) and dialysis patients (4D study, n=544). The association between LOY and mortality, combined cardiovascular and heart failure-specific end points, and echocardiographic measures was assessed. RESULTS: In CARE for HOMe, the frequency of LOY increased with age. LOY >17% was associated with increased mortality (heart rate, 2.58 [95% CI, 1.33–5.03]) and risk for cardiac decompensation or death (heart rate, 2.30 [95% CI, 1.23–4.27]). Patients with LOY >17% showed a significant decline of ejection fraction and an increase of E/E’ within 5 years. Consistently, in the 4D study, LOY >17% was significantly associated with increased mortality (heart rate, 2.76 [95% CI, 1.83–4.16]), higher risk of death due to heart failure and sudden cardiac death (heart rate, 4.11 [95% CI, 2.09–8.08]), but not atherosclerotic events. Patients with LOY >17% showed significantly higher plasma levels of soluble interleukin 1 receptor-like 1, a biomarker for myocardial fibrosis. Mechanistically, intermediate monocytes from patients with LOY >17% showed significantly higher C-C chemokine receptor type 2 expression and higher plasma levels of the C-C chemokine receptor type 2 chemokine (C-C motif) ligand 2, which may have contributed to increased heart failure events. CONCLUSIONS: LOY identifies male patients with chronic kidney disease at high risk for mortality and heart failure events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicChromosomes, Human, YHumansMaleAgedMiddle AgedCardiovascular DiseasesHeart FailureAged, 80 and overRisk FactorsFibrosis

Stichwörter der Autor:innen

LOYchronic kidney diseaseheart failureloss of Y-chromosome

Autor:innen und Institutionen

  • 1Goethe University Frankfurt's University Hospital, Department of Internal Medicine 4, Nephrology (T.S., S.R.P., M.G., T.S., M.W.).
  • University Hospital, Department of Medicine, Cardiology (S.C., D.M.L.).
  • German Center for Cardiovascular Research DZHK, Berlin, Germany (S.C., D.M.L., S.D., A.M.Z.).
  • Else Kroener-Fresenius Center for Nephrological Research (T.S., S.R.P., M.G., T.S., M.W.).
  • Institute for Cardiovascular Regeneration (T.R., S.D., A.M.Z.), Germany.
  • Hôpital Robert Schumann, Hôpital Kirchberg, Luxembourg City, Luxembourg (S.Z.).

ORCID-Profile: Stephen Zewinger, Sammy R Patyna, David M Leistner, Christoph Wanner, Winfried März, Stefanie Dimmeler, Andreas M Zeiher, Thimoteus Speer

Zitieren

APA

Weyrich, M., Cremer, S., Gerster, M., Sarakpi, T., Rasper, T., Zewinger, S., Patyna, S. R., Leistner, D. M., Heine, G. H., Wanner, C., März, W., Fliser, D., Dimmeler, S., Zeiher, A. M., & Speer, T. (2024). Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease. Circulation, 150(10), 746-757. https://doi.org/10.1161/circulationaha.124.069139

Vancouver

Weyrich M, Cremer S, Gerster M, Sarakpi T, Rasper T, Zewinger S, et al. Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease. Circulation. 2024;150(10):746-757. doi:10.1161/circulationaha.124.069139

BibTeX
@article{Weyrich2024,
  author = {Weyrich, Michael and Cremer, Sebastian and Gerster, Martin and Sarakpi, Tamim and Rasper, Tina and Zewinger, Stephen and Patyna, Sammy R and Leistner, David M and Heine, Gunnar H and Wanner, Christoph and März, Winfried and Fliser, Danilo and Dimmeler, Stefanie and Zeiher, Andreas M and Speer, Thimoteus},
  title = {Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease},
  journal = {Circulation},
  year = {2024},
  volume = {150},
  number = {10},
  pages = {746--757},
  doi = {10.1161/circulationaha.124.069139}
}
Kostenlos starten →